Skip to content

A Study on the Treatment of Premature Ejaculation

A Study on the Treatment of Premature Ejaculation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-jRCT1051250068
Enrollment
Unknown
Registered
2025-07-14
Start date
2025-07-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Premature Ejaculation

Interventions

None listed

Sponsors

Hirayama Takashi
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: Patients who meet all of the following criteria will be eligible for the study: Individuals aged 18 years or older Individuals with the capacity to provide informed consent Individuals who receive a thorough explanation of the treatment along with the informed consent document and voluntarily provide written consent Individuals deemed by the attending physician to require this treatment

Exclusion criteria

Exclusion criteria: Exclusion Criteria Patients will be excluded if they meet any of the following conditions: Use of narcotics or stimulants History of allergy or hypersensitivity to SSRIs or alpha-1 adrenergic blockers Currently taking other psychiatric medications such as SSRI, SNRI, or MAO inhibitors (paroxetine is allowed) Diagnosis of severe psychiatric disorder such as depression, schizophrenia, or bipolar disorder, or serious physical illness such as heart, liver, or kidney dysfunction

Design outcomes

Primary

MeasureTime frame
PEDT (Premature Ejaculation Diagnostic Tool) PEP (Premature Ejaculation Profile) IELT (Intravaginal Ejaculatory Latency Time: self-reported via interview or diary/logbook)

Secondary

MeasureTime frame
subjective symptoms, etc.

Contacts

Public ContactTakashi Hirayama

OSAKA UMEDA SHINSHI CLINIC

hirayama@gents-clinic.com+81-9046551882

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026